CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-26 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −5,000 | $44.75 | $224K | 16,009 |
| 2026-06-26 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −5,000 | $45.00 | $225K | 75,753 |
| 2026-06-26 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −5,000 | $45.00 | $225K | 75,753 |
| 2026-06-26 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −15,000 | $45.64 | $685K | 1,647 |
| 2026-06-18 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −10,000 | $40.24 | $402K | 16,248 |
| 2026-06-18 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −15,000 | $40.21 | $603K | 1,647 |
| 2026-06-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −4,375 | $35.00 | $153K | 75,753 |
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −3,500 | $32.83 | $115K | 18,300 |
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −3,500 | $32.82 | $115K | 18,300 |
| 2026-05-11 | Wotton Paul K Director | Sale | −2,500 | $33.05 | $83K | 26,302 |
| 2026-05-11 | Wotton Paul K Director | Sale | −7,500 | $32.64 | $245K | 18,802 |
| 2026-05-07 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −5,000 | $40.50 | $203K | 21,009 |
| 2026-05-07 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −1,422 | $40.50 | $58K | 1,118 |
| 2026-05-06 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −3,433 | $38.00 | $130K | 2,540 |
| 2026-04-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −3,472 | $35.00 | $122K | 75,556 |
| 2026-03-23 | Hagen Heidi Director | Sale 10b5-1 | −15,000 | $32.41 | $486K | 31,850 |
| 2026-03-02 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −6,421 | $34.75 | $223K | 1,262 |
| 2026-03-02 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −15,000 | $35.36 | $530K | 1,262 |
| 2026-03-02 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −10,305 | $35.30 | $364K | 16,080 |
| 2026-02-11 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −7,000 | $34.66 | $243K | 15,100 |
Page 2 of 14 · 276 trades